Last reviewed · How we verify
NCT05150184: IsoMic
Isolation and Characterization of Multiple Microbial Species From Diverse Healthy Adults
trial testing Non-interventional in Human Microbiome in 52 participants. Completed in 23 May 2023.
23 March 2023
Quick facts
| Lead sponsor | Danisco |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 52 |
| Start date | 17 November 2021 |
| Primary completion | 23 March 2023 |
| Estimated completion | 23 May 2023 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Non-interventional
Conditions studied
- Human Microbiome — all drugs for Human Microbiome →
Sponsor
Danisco — full company profile →
Who can join
Adults 18 to 50, any sex, with Human Microbiome. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Isolation and characterization of fecal/oral/skin/nasal/throat microbial species from a diverse cohort of healthy adults.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
<i>Akkermansia</i> beyond muciniphila - emergence of new species <i>Akkermansia massiliensis</i> sp. nov.
Kumar R, Hasselwander O, Kane H, Hibberd AA. · · 2024 · cited 3× · PMID 39421258 · DOI 10.20517/mrr.2024.28
Verify or expand the search:
- PubMed search for NCT05150184
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Non-interventional
Trials testing the same drug.
- NCT06798298 — A Safety and Efficacy Long-Term Follow-up Study of Adult Participants Treated With Gene Modified T Cells · recruiting
- NCT06746883 — A Study to Assess the Safety and Risk of Hypersensitivity Reactions of Sulbactam-durlobactam in Adults With Acinetobacte · recruiting
- NCT06622798 — Exploratory Study on the Correlation Between HRD Score and PARPi Efficacy Based on Chinese Ovarian Cancer Patients · recruiting
- NCT06784154 — The Role of Ectopic Fat and Heart Attack Risk in HIV · recruiting
- NCT06277037 — Long-Term Follow-up Study for Subjects With CHB Previously Treated With Imdusiran (AB729) · recruiting
Other recruiting trials for Human Microbiome
Currently open trials in the same condition.
- NCT06812091 — Human Microbiome Research and Development for Overcoming Pediatric Diseases · recruiting
Other Danisco trials
Trials by the same sponsor.
- NCT04231162 — Effect of an 8-week Bifidobacterium Lactis HN019 Supplementation on Functional Constipation · NA · completed
- NCT04125810 — A Study to Assess the Safety and Efficacy of Probiotic to Modulate Psychological Stress · Phase 2 · completed
- NCT03814668 — Effect of Probiotic Supplementation on Lactose Maldigestion Induced by Lactose Solution · NA · completed
- NCT03659747 — Effect of Probiotic Supplementation on Lactose Maldigestion Induced by Fat-free Milk · NA · completed
- NCT03187457 — PreFem: "What Happens to the Vaginal Microbiota When a BV Infection is Treated With Metronidazole?" · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05150184 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Danisco
- Last refreshed: 7 September 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05150184.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing